(1)
Mjali, A.; Obaid, M. M.; Matti, B. F.; Abbas, N. T. Treatment Outcomes of Nilotinib As Second Line Therapy for Chronic Myeloid Leukemia Patients in Karbala Province of Iraq. Asian Pac J Cancer Care 2022, 7, 267-272.